Zhiyan Zhan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhiyan Zhan has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Li Hong
Department of Clinical Nutrition, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine
11 shared publications Jing Li
Department of Clinical Nutrition, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine
5 shared publicationsLiya Pan
Department of Clinical Nutrition, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China
4 shared publications- Wenxue Liu
Department of Obstetrics and Gynecology, Zhongshan Hospital, Fudan University, Shanghai, China
4 shared publications - Ying Xiang
Department of Laboratory Medicine, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
3 shared publications Chengchen Zhang
Clinical Research Center, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China
2 shared publications
Latest Publications
- Open Access
- 9 November 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (11) , 866
Nonlinear Association Between Lithocholic Acid-Related Metabolism and Dysglycemia in Pediatric Obesity
Background: Bile acids regulate glucose metabolism through enterohepatic signaling and gut microbiota-mediated transformations. However, the role of specific bile acid subtypes, particularly lithocholic acid (LCA) and its derivatives, in pediatric obesity remains incompletely understood. Methods: In this cross-sectional study, 149 children with obesity underwent comprehensive metabolic assessment, including a 75-g oral glucose tolerance test (OGTT) and fasting serum bile acid profiling using liquid chromatography–tandem mass spectrometry (LC–MS/MS). Bile acid-derived indices were used for unsupervised clustering to identify metabolic phenotypes. Associations between LCA-related indices and dysglycemia (defined as HbA1c ≥ 5.7% and/or 2-h plasma glucose ≥ 7.8 mmol/L) were evaluated using multivariable regression models. The LCA derivative sum was analyzed separately using tertile categories and continuous linear and quadratic models. Cluster-stratified patterns were further assessed. Results: Three bile acid-derived clusters with distinct metabolic profiles were identified. Despite similar anthropometric characteristics, clusters differed significantly in glycemic status and insulin dynamics. LCA-related bile acid indices showed a non-monotonic redistribution across clusters. Compared with the lowest tertile, adjusted odds ratios for dysglycemia were 1.44 (95% CI: 0.62–3.37) for the intermediate tertile and 0.33 (0.13–0.83) for the highest tertile. The continuous linear model showed an inverse association per SD increase (OR 0.646 [0.441–0.946]). A separate continuous quadratic model suggested an inverted U-shaped exposure–response pattern, describing variation across the continuous exposure range rather than comparisons between tertile categories. Interaction analyses did not demonstrate a statistically significant modification of the association for the primary outcome, although analyses of continuous glycemic traits suggested potential heterogeneity across clusters. Conclusions: Bile acid-based clustering identifies distinct metabolic phenotypes in pediatric obesity. LCA-related bile acid metabolism shows nonlinear associations with dysglycemia and may exhibit heterogeneity across metabolic phenotypes. These findings highlight the importance of considering bile acid subtype specificity and metabolic context in understanding bile acid–glucose interactions.
- 9 November 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (11) , 866
Open AccessNonlinear Association Between Lithocholic Acid-Related Metabolism and Dysglycemia in Pediatric Obesity
Background: Bile acids regulate glucose metabolism through enterohepatic signaling and gut microbiota-mediated transformations. However, the role of specific bile acid subtypes, particularly lithocholic acid (LCA) and its derivatives, in pediatric obesity remains incompletely understood. Methods: In this cross-sectional study, 149 children with obesity underwent comprehensive metabolic assessment, including a 75-g oral glucose tolerance test (OGTT) and fasting serum bile acid profiling using liquid chromatography–tandem mass spectrometry (LC–MS/MS). Bile acid-derived indices were used for unsupervised clustering to identify metabolic phenotypes. Associations between LCA-related indices and dysglycemia (defined as HbA1c ≥ 5.7% and/or 2-h plasma glucose ≥ 7.8 mmol/L) were evaluated using multivariable regression models. The LCA derivative sum was analyzed separately using tertile categories and continuous linear and quadratic models. Cluster-stratified patterns were further assessed. Results: Three bile acid-derived clusters with distinct metabolic profiles were identified. Despite similar anthropometric characteristics, clusters differed significantly in glycemic status and insulin dynamics. LCA-related bile acid indices showed a non-monotonic redistribution across clusters. Compared with the lowest tertile, adjusted odds ratios for dysglycemia were 1.44 (95% CI: 0.62–3.37) for the intermediate tertile and 0.33 (0.13–0.83) for the highest tertile. The continuous linear model showed an inverse association per SD increase (OR 0.646 [0.441–0.946]). A separate continuous quadratic model suggested an inverted U-shaped exposure–response pattern, describing variation across the continuous exposure range rather than comparisons between tertile categories. Interaction analyses did not demonstrate a statistically significant modification of the association for the primary outcome, although analyses of continuous glycemic traits suggested potential heterogeneity across clusters. Conclusions: Bile acid-based clustering identifies distinct metabolic phenotypes in pediatric obesity. LCA-related bile acid metabolism shows nonlinear associations with dysglycemia and may exhibit heterogeneity across metabolic phenotypes. These findings highlight the importance of considering bile acid subtype specificity and metabolic context in understanding bile acid–glucose interactions.
- Open Access
- 29 October 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (11) , 2476
ApoE and Fibroblast–Macrophage Interaction in the Aganglionic Segment of Hirschsprung’s Disease-Associated Enterocolitis
Background: The pathogenesis of Hirschsprung’s disease-associated enterocolitis (HAEC) remains unclear. Currently, no definitive studies have elucidated the communication between intestinal macrophages and fibroblasts during the development of HAEC, nor their specific functional roles in this process. Methods: The first step is utilizing single-cell transcriptomics and spatial transcriptomic sequencing techniques to validate the phenotypes and corresponding spatial location characteristics of intestinal fibroblasts in the patient with HAEC. The second is verifying the mechanism whereby specific subtypes of fibroblasts and macrophages communicate via apolipoprotein E (ApoE) and modulate corresponding inflammatory pathways using co-culture, Western blot and other molecular biology techniques. Results: As HAEC progressed, JUN expression was significantly upregulated in CTHRC1+PRRX1+ fibroblasts enriched in the submucosal layer in the aganglionic segment. In vitro experiments showed JUN-overexpressing 3T3-L1 cells exhibited increased ApoE secretion. ApoE may interact with macrophages and potentially suppress their inflammation through the p38/MAPK and NF-κB pathways. Conclusions:CTHRC1+PRRX1+ fibroblasts and ApoE may represent a potential mechanistic target for future investigation into inhibiting the progression of the aganglionic segment in HAEC and treating colitis.
- 29 October 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (11) , 2476
Open AccessApoE and Fibroblast–Macrophage Interaction in the Aganglionic Segment of Hirschsprung’s Disease-Associated Enterocolitis
Background: The pathogenesis of Hirschsprung’s disease-associated enterocolitis (HAEC) remains unclear. Currently, no definitive studies have elucidated the communication between intestinal macrophages and fibroblasts during the development of HAEC, nor their specific functional roles in this process. Methods: The first step is utilizing single-cell transcriptomics and spatial transcriptomic sequencing techniques to validate the phenotypes and corresponding spatial location characteristics of intestinal fibroblasts in the patient with HAEC. The second is verifying the mechanism whereby specific subtypes of fibroblasts and macrophages communicate via apolipoprotein E (ApoE) and modulate corresponding inflammatory pathways using co-culture, Western blot and other molecular biology techniques. Results: As HAEC progressed, JUN expression was significantly upregulated in CTHRC1+PRRX1+ fibroblasts enriched in the submucosal layer in the aganglionic segment. In vitro experiments showed JUN-overexpressing 3T3-L1 cells exhibited increased ApoE secretion. ApoE may interact with macrophages and potentially suppress their inflammation through the p38/MAPK and NF-κB pathways. Conclusions:CTHRC1+PRRX1+ fibroblasts and ApoE may represent a potential mechanistic target for future investigation into inhibiting the progression of the aganglionic segment in HAEC and treating colitis.
- Open Access
- 1 October 2026
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 13, 1932946
Food-based formula modulates gut microbial homeostasis and inflammatory responses following LPS challenge in mice
Background: Oral nutritional supplements (ONSs) are widely used to support patients with malnutrition or chronic diseases. However, their potential effects on inflammatory recovery and gut microbial composition remain insufficiently understood. This study evaluated a novel whole-food-based formula (FBF) composed of natural food-derived ingredients and investigated its effects on inflammation recovery and gut microbiota in a murine model of lipopolysaccharide (LPS)-induced low-grade inflammation. Methods: 21 male C57BL/6J mice were randomly assigned to a healthy control (HC) group, a milk-based formula (MBF) group, or a food-based formula (FBF) group. Mild systemic inflammation was induced by intraperitoneal injection of LPS (3 mg/kg). After LPS administration, mice received dietary intervention for 10 days. Serum inflammatory cytokines, colonic histopathology, and gut microbiota profiles were evaluated by ELISA, hematoxylin–eosin staining, and 16S rRNA gene sequencing, respectively. Results: Serum IL-6 concentrations were elevated in the MBF group compared with healthy controls ( p < 0.05), whereas no significant difference was observed between the FBF group and healthy controls. Histological evaluation showed a tendency toward reduced mucosal disruption and inflammatory cell infiltration in FBF-treated mice, although the differences in histological scores were not statistically significant. FBF was also associated with increased microbial richness and diversity, as indicated by higher ACE, Chao1, Shannon, and Simpson indices. Principal coordinate analysis and non-metric multidimensional scaling revealed a microbial community structure closer to that of healthy controls in the FBF group. Taxonomic analysis revealed that FBF reduced the relative abundance of Erysipelotrichaceae and maintained Lachnospiraceae_NK4A136_group abundance. Conclusion: A whole-food-based nutritional formula was associated with lower serum IL-6 levels and distinct gut microbial compositional profiles compared with a milk-based formula following LPS-induced inflammation. These findings suggest FBF may influence inflammatory recovery and gut microbial composition; however, further functional and mechanistic studies are required to clarify its biological effects.
- 1 October 2026
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 13, 1932946
Open AccessFood-based formula modulates gut microbial homeostasis and inflammatory responses following LPS challenge in mice
Background: Oral nutritional supplements (ONSs) are widely used to support patients with malnutrition or chronic diseases. However, their potential effects on inflammatory recovery and gut microbial composition remain insufficiently understood. This study evaluated a novel whole-food-based formula (FBF) composed of natural food-derived ingredients and investigated its effects on inflammation recovery and gut microbiota in a murine model of lipopolysaccharide (LPS)-induced low-grade inflammation. Methods: 21 male C57BL/6J mice were randomly assigned to a healthy control (HC) group, a milk-based formula (MBF) group, or a food-based formula (FBF) group. Mild systemic inflammation was induced by intraperitoneal injection of LPS (3 mg/kg). After LPS administration, mice received dietary intervention for 10 days. Serum inflammatory cytokines, colonic histopathology, and gut microbiota profiles were evaluated by ELISA, hematoxylin–eosin staining, and 16S rRNA gene sequencing, respectively. Results: Serum IL-6 concentrations were elevated in the MBF group compared with healthy controls ( p < 0.05), whereas no significant difference was observed between the FBF group and healthy controls. Histological evaluation showed a tendency toward reduced mucosal disruption and inflammatory cell infiltration in FBF-treated mice, although the differences in histological scores were not statistically significant. FBF was also associated with increased microbial richness and diversity, as indicated by higher ACE, Chao1, Shannon, and Simpson indices. Principal coordinate analysis and non-metric multidimensional scaling revealed a microbial community structure closer to that of healthy controls in the FBF group. Taxonomic analysis revealed that FBF reduced the relative abundance of Erysipelotrichaceae and maintained Lachnospiraceae_NK4A136_group abundance. Conclusion: A whole-food-based nutritional formula was associated with lower serum IL-6 levels and distinct gut microbial compositional profiles compared with a milk-based formula following LPS-induced inflammation. These findings suggest FBF may influence inflammatory recovery and gut microbial composition; however, further functional and mechanistic studies are required to clarify its biological effects.
- 17 April 2026
- Published by Springer Nature in Inflammation Research
- Vol. 75 (1)
Macrophages with ITIH4 overexpression attenuate inflammatory responses and regulate intestinal epithelial cells
Inter-alpha-trypsin inhibitor heavy chain 4 (ITIH4) is an acute phage protein and secretory protein that is highly related to inflammation. However, the expression profile and function of ITIH4 in macrophage-mediated inflammation are still unclear. Quantitative proteomics based on mass spectrometry was performed to explore differential protein expression in bone marrow-derived macrophages (BMDMs) subjected to the indicated treatments. Western blot and qRT-PCR assays were performed to confirm the expression of ITIH4 in macrophages. ITIH4 was overexpressed and knocked down in Raw264.7 cells, and ITIH4 was knocked down in THP-1 cells, after which the function and molecular mechanism of ITIH4 in macrophages were investigated. Immunohistochemical staining and online bioinformatics tools were used to explore the expression of ITIH4 in the inflamed colon. In addition, CCK8, scratch wound healing, RNA-seq, qRT-PCR and Western blot assays were performed to explore the function and mechanism of macrophages with ITIH4 overexpression in colonic epithelial cells. Our findings demonstrated that the expression of full-length ITIH4 increased in pro-inflammatory macrophages resulting from a decrease in cleavage, whereas treatment with 4-octyl itaconate (OI) promoted the synthesis and secretion of full-length ITIH4. We overexpressed or knocked down ITIH4 in macrophages, subsequently revealed that ITIH4 modulated anti-inflammatory responses via the NF-κB signaling pathway in macrophages. Moreover, macrophages with ITIH4 overexpression activated cAMP signaling pathway to enhance the viability and tight junction integrity of colonic epithelial cells. This study suggests that ITIH4 plays crucial roles in the inflammatory response of macrophages and may be an important molecule that regulates macrophage-epithelium interactions. Our findings shed new light into the molecular mechanism underlying macrophage drives intestinal inflammation and highlight ITIH4 as a therapeutic target for mitigating macrophages-induced intestinal damage.
- 17 April 2026
- Published by Springer Nature in Inflammation Research
- Vol. 75 (1)
Macrophages with ITIH4 overexpression attenuate inflammatory responses and regulate intestinal epithelial cells
Inter-alpha-trypsin inhibitor heavy chain 4 (ITIH4) is an acute phage protein and secretory protein that is highly related to inflammation. However, the expression profile and function of ITIH4 in macrophage-mediated inflammation are still unclear. Quantitative proteomics based on mass spectrometry was performed to explore differential protein expression in bone marrow-derived macrophages (BMDMs) subjected to the indicated treatments. Western blot and qRT-PCR assays were performed to confirm the expression of ITIH4 in macrophages. ITIH4 was overexpressed and knocked down in Raw264.7 cells, and ITIH4 was knocked down in THP-1 cells, after which the function and molecular mechanism of ITIH4 in macrophages were investigated. Immunohistochemical staining and online bioinformatics tools were used to explore the expression of ITIH4 in the inflamed colon. In addition, CCK8, scratch wound healing, RNA-seq, qRT-PCR and Western blot assays were performed to explore the function and mechanism of macrophages with ITIH4 overexpression in colonic epithelial cells. Our findings demonstrated that the expression of full-length ITIH4 increased in pro-inflammatory macrophages resulting from a decrease in cleavage, whereas treatment with 4-octyl itaconate (OI) promoted the synthesis and secretion of full-length ITIH4. We overexpressed or knocked down ITIH4 in macrophages, subsequently revealed that ITIH4 modulated anti-inflammatory responses via the NF-κB signaling pathway in macrophages. Moreover, macrophages with ITIH4 overexpression activated cAMP signaling pathway to enhance the viability and tight junction integrity of colonic epithelial cells. This study suggests that ITIH4 plays crucial roles in the inflammatory response of macrophages and may be an important molecule that regulates macrophage-epithelium interactions. Our findings shed new light into the molecular mechanism underlying macrophage drives intestinal inflammation and highlight ITIH4 as a therapeutic target for mitigating macrophages-induced intestinal damage.
- 8 December 2025
- Published by Wiley in Advanced Therapeutics
- Vol. 8 (12)
Targeting USP49 and ATAD5 Inhibits Cisplatin Resistance by Impairing DNA Damage Repair in Ovarian Cancer
USP49 regulates various cellular processes as a deubiquitinase during the development of cancer. However, the roles of USP49 in ovarian cancer (OC) remain obscure. Here, it is shown that USP49 is amplified in OC, which is associated with elevated mRNA expression. Although USP49 inhibition has no significant influence on the proliferation of OC cells, USP49 overexpression promotes drug resistance to cisplatin treatment in Tp53‐WT OC cells. Mechanistically, USP49 decreases ubiquitination of γH2AX and enhances DNA damage repair, impairing cell apoptosis of OC cells in response to cisplatin treatment. In addition, co‐expression of USP49 and ATAD5 is identified in OC, and inhibition of USP49 and ATAD5 increases drug sensitivity to cisplatin in Tp53‐WT OC cells. In conclusion, these findings demonstrate the role of USP49 on cisplatin resistance and suggest that repressing USP49 and ATAD5 can be a potential therapeutic strategy for cisplatin‐resistant ovarian cancer.
- 8 December 2025
- Published by Wiley in Advanced Therapeutics
- Vol. 8 (12)
Targeting USP49 and ATAD5 Inhibits Cisplatin Resistance by Impairing DNA Damage Repair in Ovarian Cancer
USP49 regulates various cellular processes as a deubiquitinase during the development of cancer. However, the roles of USP49 in ovarian cancer (OC) remain obscure. Here, it is shown that USP49 is amplified in OC, which is associated with elevated mRNA expression. Although USP49 inhibition has no significant influence on the proliferation of OC cells, USP49 overexpression promotes drug resistance to cisplatin treatment in Tp53‐WT OC cells. Mechanistically, USP49 decreases ubiquitination of γH2AX and enhances DNA damage repair, impairing cell apoptosis of OC cells in response to cisplatin treatment. In addition, co‐expression of USP49 and ATAD5 is identified in OC, and inhibition of USP49 and ATAD5 increases drug sensitivity to cisplatin in Tp53‐WT OC cells. In conclusion, these findings demonstrate the role of USP49 on cisplatin resistance and suggest that repressing USP49 and ATAD5 can be a potential therapeutic strategy for cisplatin‐resistant ovarian cancer.
- 15 August 2025
- Published by Elsevier in Biochemical Pharmacology
- Vol. 242 (Pt 1) , 117243
Oncogenic GOPC-ROS1 fusion promotes the formation of lymphatic malformations by impairing tight junction and its crizotinib resistance through repressing ferroptosis
- 15 August 2025
- Published by Elsevier in Biochemical Pharmacology
- Vol. 242 (Pt 1) , 117243
Oncogenic GOPC-ROS1 fusion promotes the formation of lymphatic malformations by impairing tight junction and its crizotinib resistance through repressing ferroptosis
- 30 July 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 779, 152427
DPEP2 deficiency enhances infiltration of macrophages by Akt1-VIM axis
- 30 July 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 779, 152427
DPEP2 deficiency enhances infiltration of macrophages by Akt1-VIM axis
- Open Access
- 4 June 2025
- Published by Wiley in Advanced Biology
- Vol. 9 (9) , e00761
HMGB1 Derived from the Pyroptotic Microenvironment Promotes Macrophage Extracellular Traps in Hirschsprung‐Associated Enterocolitis
Hirschsprung‐associated enterocolitis (HAEC) is the most common and severe complication in patients with Hirschsprung's disease (HSCR) and is characterized by high morbidity, frequent recurrence and substantial mortality. The formation of macrophage extracellular traps (METs), a novel inflammatory mode of cell death, plays a significant role in the progression of various inflammatory diseases. However, the mechanisms underlying METs formation and their role in the progression of HAEC remain unclear. Here, the findings indicate that METs formation induced by the pyroptotic microenvironment enhances inflammatory responses and induces colonic epithelial cells (CECs) injury in HAEC. Mechanistically, high mobility group box 1 protein (HMGB1), derived from this pyroptotic environment, mediates METs formation through toll‐like receptor 4 (TLR4)‐p38 MAPK/p65 NF‐kB signaling pathways. Furthermore, incubation of CECs with METs induces suppression of cell viability, more production of reactive oxygen species (ROS) and pyroptosis. In conclusion, HMGB1 mediates the communication between pyroptotic microenvironment and METs formation, triggering enhanced inflammatory responses and damage to CECs. Targeting HMGB1 presents a potential therapeutic strategy for HAEC.
- 4 June 2025
- Published by Wiley in Advanced Biology
- Vol. 9 (9) , e00761
Open AccessHMGB1 Derived from the Pyroptotic Microenvironment Promotes Macrophage Extracellular Traps in Hirschsprung‐Associated Enterocolitis
Hirschsprung‐associated enterocolitis (HAEC) is the most common and severe complication in patients with Hirschsprung's disease (HSCR) and is characterized by high morbidity, frequent recurrence and substantial mortality. The formation of macrophage extracellular traps (METs), a novel inflammatory mode of cell death, plays a significant role in the progression of various inflammatory diseases. However, the mechanisms underlying METs formation and their role in the progression of HAEC remain unclear. Here, the findings indicate that METs formation induced by the pyroptotic microenvironment enhances inflammatory responses and induces colonic epithelial cells (CECs) injury in HAEC. Mechanistically, high mobility group box 1 protein (HMGB1), derived from this pyroptotic environment, mediates METs formation through toll‐like receptor 4 (TLR4)‐p38 MAPK/p65 NF‐kB signaling pathways. Furthermore, incubation of CECs with METs induces suppression of cell viability, more production of reactive oxygen species (ROS) and pyroptosis. In conclusion, HMGB1 mediates the communication between pyroptotic microenvironment and METs formation, triggering enhanced inflammatory responses and damage to CECs. Targeting HMGB1 presents a potential therapeutic strategy for HAEC.
- Open Access
- 28 February 2025
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 32 (7) , 1336-1352
The Trim32-DPEP2 axis is an inflammatory switch in macrophages during intestinal inflammation
The mechanisms via which inflammatory macrophages mediate intestinal inflammation are not completely understood. Herein, using merged analysis of RNA sequencing and mass spectrometry-based quantitative proteomics, we detected differences between proteomic and transcriptomic data in activated macrophages. Dipeptidase-2 (DPEP2), a member of the DPEP family, was highly expressed and then downregulated sharply at the protein level but not at the mRNA level in macrophages in response to inflammatory stimulation. Suppression of DPEP2 not only enhanced macrophage-mediated intestinal inflammation in vivo but also promoted the transduction of inflammatory pathways in macrophages in vitro. Mechanistically, overexpressed DPEP2 inhibited the transduction of inflammatory signals by resisting MAK3K7 in inactivated macrophages, whereas DPEP2 degradation by activated Trim32 resulted in strong activation of NF-κB and p38 MAPK signaling via the release of MAK3K7 in proinflammatory macrophages during the development of intestinal inflammation. The Trim32-DPEP2 axis accumulates the potential energy of inflammation in macrophages. These results identify DPEP2 as a key regulator of macrophage-mediated intestinal inflammation. Thus, the Trim32-DPEP2 axis may be a potential therapeutic target for the treatment of intestinal inflammation.
- 28 February 2025
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 32 (7) , 1336-1352
Open AccessThe Trim32-DPEP2 axis is an inflammatory switch in macrophages during intestinal inflammation
The mechanisms via which inflammatory macrophages mediate intestinal inflammation are not completely understood. Herein, using merged analysis of RNA sequencing and mass spectrometry-based quantitative proteomics, we detected differences between proteomic and transcriptomic data in activated macrophages. Dipeptidase-2 (DPEP2), a member of the DPEP family, was highly expressed and then downregulated sharply at the protein level but not at the mRNA level in macrophages in response to inflammatory stimulation. Suppression of DPEP2 not only enhanced macrophage-mediated intestinal inflammation in vivo but also promoted the transduction of inflammatory pathways in macrophages in vitro. Mechanistically, overexpressed DPEP2 inhibited the transduction of inflammatory signals by resisting MAK3K7 in inactivated macrophages, whereas DPEP2 degradation by activated Trim32 resulted in strong activation of NF-κB and p38 MAPK signaling via the release of MAK3K7 in proinflammatory macrophages during the development of intestinal inflammation. The Trim32-DPEP2 axis accumulates the potential energy of inflammation in macrophages. These results identify DPEP2 as a key regulator of macrophage-mediated intestinal inflammation. Thus, the Trim32-DPEP2 axis may be a potential therapeutic target for the treatment of intestinal inflammation.
- Open Access
- 8 July 2024
- Published by Wiley in Advanced Science
- Vol. 11 (34) , e2400140
KAT6A Condensates Impair PARP1 Trapping of PARP Inhibitors in Ovarian Cancer
Most clinical PARP inhibitors (PARPis) trap PARP1 in a chromatin‐bound state, leading to PARPi‐mediated cytotoxicity. PARPi resistance impedes the treatment of ovarian cancer in clinical practice. However, the mechanism by which cancer cells overcome PARP1 trapping to develop PARPi resistance remains unclear. Here, it is shown that high levels of KAT6A promote PARPi resistance in ovarian cancer, regardless of its catalytic activity. Mechanistically, the liquid‐liquid phase separation (LLPS) of KAT6A, facilitated by APEX1, inhibits the cytotoxic effects of PARP1 trapping during PARPi treatment. The stable KAT6A‐PARP1‐APEX1 complex reduces the amount of PARP1 trapped at the DNA break sites. In addition, inhibition of KAT6A LLPS, rather than its catalytic activity, impairs DNA damage repair and restores PARPi sensitivity in ovarian cancer both in vivo and in vitro. In conclusion, the findings demonstrate the role of KAT6A LLPS in fostering PARPi resistance and suggest that repressing KAT6A LLPS can be a potential therapeutic strategy for PARPi‐resistant ovarian cancer.
- 8 July 2024
- Published by Wiley in Advanced Science
- Vol. 11 (34) , e2400140
Open AccessKAT6A Condensates Impair PARP1 Trapping of PARP Inhibitors in Ovarian Cancer
Most clinical PARP inhibitors (PARPis) trap PARP1 in a chromatin‐bound state, leading to PARPi‐mediated cytotoxicity. PARPi resistance impedes the treatment of ovarian cancer in clinical practice. However, the mechanism by which cancer cells overcome PARP1 trapping to develop PARPi resistance remains unclear. Here, it is shown that high levels of KAT6A promote PARPi resistance in ovarian cancer, regardless of its catalytic activity. Mechanistically, the liquid‐liquid phase separation (LLPS) of KAT6A, facilitated by APEX1, inhibits the cytotoxic effects of PARP1 trapping during PARPi treatment. The stable KAT6A‐PARP1‐APEX1 complex reduces the amount of PARP1 trapped at the DNA break sites. In addition, inhibition of KAT6A LLPS, rather than its catalytic activity, impairs DNA damage repair and restores PARPi sensitivity in ovarian cancer both in vivo and in vitro. In conclusion, the findings demonstrate the role of KAT6A LLPS in fostering PARPi resistance and suggest that repressing KAT6A LLPS can be a potential therapeutic strategy for PARPi‐resistant ovarian cancer.